Anatomic and systemic risk factors have traditionally included crowding of the optic nerve head, male gender, hypertension, hypercoagulability, and diabetes with end-organ damage [6], but recently Hathaway et al
doi:10.1253/circj.CJ-16-0035 Warchol-Celinska E, Prejbisz A, Kadziela J, et al
Kt qu cho thy, trong nhng ngi mc bnh Parkinson c cho dng glutathione dng xt mi ba ln mi ngy trong ba thng, thy cc triu chng ca h c ci thin trong qu trnh th nghim, nhng khng nhiu hn so vi nhm gi dc
However, for individuals prioritizing convenience or needle avoidance, oral GLP-1 therapy offers a meaningful alternative